Article
Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression
6 Nov 2020
Abstract excerpt
Limited clinical benefit has been demonstrated for chimeric antigen receptor (CAR) therapy of solid tumors, but coengineering strategies to generate so-called fourth-generation (4G) CAR-T cells are advancing toward overcoming barriers in the tumor microenvironment (TME) for improved responses. In large part due to technical challenges, there are relatively few preclinical CAR therapy studies in immunocompetent,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
